Breaking News Instant updates and real-time market news.

ERJ

Embraer

$27.84

0.35 (1.27%)

, BA

Boeing

$332.98

5.62 (1.72%)

11:04
04/12/18
04/12
11:04
04/12/18
11:04

Brazilian approval of Embraer-Boeing deal not imminent, Reuters says

Boeing (BA) and Embraer (ERJ) submitted a new proposal for a tie-up to the Brazilian government on Tuesday, but government approval is not imminent, according to Reuters, citing sources.

ERJ

Embraer

$27.84

0.35 (1.27%)

BA

Boeing

$332.98

5.62 (1.72%)

  • 25

    Apr

  • 30

    May

ERJ Embraer
$27.84

0.35 (1.27%)

10/31/17
JPMS
10/31/17
DOWNGRADE
Target $21
JPMS
Neutral
Embraer downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Carlos Louro downgraded Embraer to Neutral and lowered his price target for the shares to $21 from $25. The analyst sees a more challenging margin environment for 2018 and 2019 following the company's lower than expected guidance. He assumes lower operational margins for all segments going forward.
10/31/17
10/31/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cypress Semiconductor (CY) downgraded to Equal Weight from Overweight at Barclays WITH analyst Blayne Curtis saying he believes most of the catalysts have played out and that additional margin leverage should get tougher from here. 2. Dominion Midstream (DM) was downgraded to Sector Perform from Outperform at RBC Capital and to Neutral from Buy at Mizuho. 3. Embraer (ERJ) downgraded to Neutral from Overweight at JPMorgan with analyst Carlos Louro saying he sees a more challenging margin environment for 2018 and 2019 following the company's lower than expected guidance. 4. H.B. Fuller (FUL) downgraded to Neutral from Buy at Citi with analyst Eric Petrie saying the Royal acquisition close is priced in at current share levels. 5. Iconix Brand (ICON) downgraded to Neutral from Buy at Roth Capital with analyst Dave King citing the company's announcement that its DanskinNow brand will not be renewed at Wal-Mart (WMT) beyond January 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/21/17
WELS
12/21/17
NO CHANGE
WELS
A Boeing acquisition of Embraer would be negative for Textron, says Wells Fargo
12/22/17
JEFF
12/22/17
NO CHANGE
Target $312
JEFF
Buy
Jefferies sees possible Embraer deal modestly accretive to Boeing
Jefferies analyst Sheila Kahyaoglu estimates an acquisition of Embraer (ERJ), done at a 40% premium, would be 2%, or 20c, accretive to Boeing's (BA) core earnings per share in 2020. While the transaction would be strategically beneficial for Boeing's commercial aircraft and services portfolio, it is not clear what restrictions the Brazilian government would place on any combination, Kahyaoglu tells investors in a research note. She has a Buy rating on Boeing with a $312 price target.
BA Boeing
$332.98

5.62 (1.72%)

04/04/18
BARD
04/04/18
NO CHANGE
Target $433
BARD
Outperform
Boeing should be bought on the pullback, says Baird
Baird analyst Peter Arment previewed the Q1 results for Boeing and said he expects a solid report. The analyst said proprietary aircraft delivery checks indicate better than consensus performance as the end of March delivery activity was very strong. He said he remains a buyer on the recent pullback and sees the shares on the path to $400. Arment reiterated his Outperform rating and $433 price target.
04/05/18
MSCO
04/05/18
NO CHANGE
Target $373
MSCO
Equal Weight
Boeing risk-reward improved after tariff-fueled pullback, says Morgan Stanley
China's potential 25% tariff exceeded expectations, though it was equal in size to U.S. actions under Section 301, said Morgan Stanley analyst Rajeev Lalwani, who notes that for aerospace the tariff would be levied on aircraft with an empty weight exceeding 15,000kg but less than 45,000kg. This range may include the 737-700 and 737 MAX 7, noted the analyst, who estimates the backlog of those two aircraft for China represents less than about 1% of the total. If the next step is negotiation and resolution, which Morgan Stanley believes is probable, Lalwani said he sees "a clearer path" to his price target of $373 on Boeing share, which fell 1% yesterday to $327.44. He keeps an Equal Weight rating on the stock.
04/05/18
BERN
04/05/18
NO CHANGE
BERN
Chinese tariffs negative for Boeing, limited impact, says Bernstein
Bernstein analyst Douglas Harned notes that China said it would impose a 25% tariff on U.S.-produced aircraft weighing between 15,000kg-45,000kg. The analyst sees Chinese tariffs as negative for Boeing (BA), but with limited impact if current orders and the MAX-8 remain unaffected. Harned does not see that Airbus (EADSY) would benefit materially, as narrow tariffs would offer little advantage. The risk of a trade war driven recession is now higher, but the analyst does not assume one. Harned reiterates an Outperform rating on both Boeing and Airbus.
04/12/18
SBSH
04/12/18
NO CHANGE
Target $415
SBSH
Buy
Citi sees path to 50% upside in shares of Boeing
Citi analyst Jonathan Raviv sees a path to 50% upside in shares of Boeing (BA), or a stock price above $500. The analyst keeps a Buy rating on the shares with a $415 price target. Airbus (EADSY) hosted its annual meeting on Wednesday, and surrounding media chatter touched on potentially raising A320 rates to greater than 70, although there's nothing official from the company, Raviv tells investors in a research note. Dropping that into Boeing's free cash builder supports a stock above $500 at an attractive 7% free cash flow yield, the analyst writes. He sees this as "one of several paths" to share upside for Boeing. He believes both sides are incentivized to maintain delivery plans and keeps a Buy rating on Boeing shares. Raviv believes the stock remains cheap at current levels.

TODAY'S FREE FLY STORIES

RHHBY

Roche

05:30
04/23/18
04/23
05:30
04/23/18
05:30
Hot Stocks
Genentech says 4 years of continuous Ocrevus treatment reduces RMS activity »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 21

    May

  • 30

    May

UBS

UBS

$17.66

-0.005 (-0.03%)

05:27
04/23/18
04/23
05:27
04/23/18
05:27
Earnings
UBS reports Q1 EPS CHF 0.39 vs. CHF 0.33 last year »

Reports Q1 profit before…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    May

BHVN

Biohaven Pharmaceutical

$27.19

-0.07 (-0.26%)

05:21
04/23/18
04/23
05:21
04/23/18
05:21
Hot Stocks
Biohaven announces key secondary outcome measures from rimegepant Phase 3 trials »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 12

    Jun

OPBK

OP Bancorp

05:12
04/23/18
04/23
05:12
04/23/18
05:12
Initiation
OP Bancorp initiated  »

OP Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$58.82

0.18 (0.31%)

05:11
04/23/18
04/23
05:11
04/23/18
05:11
Upgrade
Merck rating change  »

Merck upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 05

    Jun

  • 23

    Oct

BDORY

Banco do Brasil

05:04
04/23/18
04/23
05:04
04/23/18
05:04
Downgrade
Banco do Brasil rating change  »

Banco do Brasil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$99.64

-4.57 (-4.39%)

05:02
04/23/18
04/23
05:02
04/23/18
05:02
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

KORS

Michael Kors

$65.02

-0.7 (-1.07%)

04:57
04/23/18
04/23
04:57
04/23/18
04:57
Upgrade
Michael Kors rating change  »

Deutsche Bank upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$12.60

-0.47 (-3.60%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    May

AVEO

Aveo Oncology

$2.59

-0.05 (-1.89%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Aveo Oncology management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

KMB

Kimberly-Clark

$100.04

-3.3 (-3.19%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Technical Analysis
Technical Earnings Preview: Kimberly-Clark near 5-year lows ahead of earnings »

The shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 27

    Apr

  • 30

    May

INFY

Infosys

$17.38

0.21 (1.22%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Infosys to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

CIGI

Colliers International

$70.20

0.75 (1.08%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
UBS REITs analyst to hold an analyst/industry conference call »

REITs Analyst Yulico,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 01

    May

CNAT

Conatus

$3.58

0.02 (0.56%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Conatus management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Existing Home Sales to be reported at 10:00 »

March Existing Home Sales…

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

MLNX

Mellanox

$75.80

-1.45 (-1.88%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Mellanox management to meet with Loop Capital »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

APVO

Aptevo Therapeutics

$4.33

0.01 (0.23%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

April PMI Composite Flash…

04:55
04/23/18
04/23
04:55
04/23/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

IFRX

InflaRx

$38.78

1.67 (4.50%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
InflaRx has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts discuss dental…

LUK

Leucadia

$24.02

-0.1 (-0.41%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Leucadia management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    May

  • 04

    Oct

CNK

Cinemark

$39.66

-0.74 (-1.83%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Cinemark management to meet with MKM Partners »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

CRAY

Cray

$22.40

-0.2 (-0.88%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Cray management to meet with Craig Hallum »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.